- Home
- RCEL vs MCN Comparison
RCEL vs MCN Comparison
Compare RCEL & MCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCEL
- MCN
- Stock Information
- Founded
- RCEL N/A
- MCN 2004
- Country
- RCEL United States
- MCN Canada
- Employees
- RCEL N/A
- MCN N/A
- Industry
- RCEL Medical/Dental Instruments
- MCN
- Sector
- RCEL Health Care
- MCN
- Exchange
- RCEL Nasdaq
- MCN Nasdaq
- Market Cap
- RCEL 140.5M
- MCN 130.3M
- IPO Year
- RCEL N/A
- MCN N/A
- Fundamental
- Price
- RCEL $5.33
- MCN $6.14
- Analyst Decision
- RCEL Strong Buy
- MCN
- Analyst Count
- RCEL 4
- MCN 0
- Target Price
- RCEL $13.75
- MCN N/A
- AVG Volume (30 Days)
- RCEL 267.6K
- MCN 52.9K
- Earning Date
- RCEL 11-06-2025
- MCN 01-01-0001
- Dividend Yield
- RCEL N/A
- MCN 9.96%
- EPS Growth
- RCEL N/A
- MCN N/A
- EPS
- RCEL N/A
- MCN N/A
- Revenue
- RCEL $74,884,000.00
- MCN N/A
- Revenue This Year
- RCEL $22.92
- MCN N/A
- Revenue Next Year
- RCEL $37.07
- MCN N/A
- P/E Ratio
- RCEL N/A
- MCN N/A
- Revenue Growth
- RCEL 38.32
- MCN N/A
- 52 Week Low
- RCEL $3.60
- MCN $6.69
- 52 Week High
- RCEL $14.16
- MCN $8.60
- Technical
- Relative Strength Index (RSI)
- RCEL 49.55
- MCN 44.63
- Support Level
- RCEL $5.14
- MCN $6.10
- Resistance Level
- RCEL $5.61
- MCN $6.39
- Average True Range (ATR)
- RCEL 0.24
- MCN 0.08
- MACD
- RCEL -0.03
- MCN -0.01
- Stochastic Oscillator
- RCEL 41.94
- MCN 22.58
About RCEL Avita Medical Inc.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.
About MCN Madison Covered Call & Equity Strategy Fund
XAI Madison Equity Premium Income Fund is an investment management company. The Fund invests in an actively managed equity portfolio comprised of individual stocks and covered call options. The Fund's primary investment objective is to provide high level of current income and gains, with a secondary objective of capital appreciation.